Found: 7
Select item for more details and to access through your institution.
Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 327, doi. 10.3390/vaccines10020327
- By:
- Publication type:
- Article
Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 360, doi. 10.3390/vaccines9040360
- By:
- Publication type:
- Article
Pharmacokinetics of Certoparin During In Vitro and In Vivo Dialysis.
- Published in:
- Artificial Organs, 2015, v. 39, n. 11, p. 951, doi. 10.1111/aor.12475
- By:
- Publication type:
- Article
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 5, p. 756, doi. 10.3390/v13050756
- By:
- Publication type:
- Article
Use of cinacalcet in a patient on long-term dialysis with end-stage renal failure and refractory secondary hyperparathyroidism.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. 2, p. 637
- By:
- Publication type:
- Article
pp60c-src is required for the induction of a quiescent mesangial cell phenotype.
- Published in:
- Kidney International, 1997, v. 51, n. 1, p. 110, doi. 10.1038/ki.1997.14
- By:
- Publication type:
- Article
A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane study.
- Published in:
- BMC Nephrology, 2012, v. 13, n. 1, p. 50, doi. 10.1186/1471-2369-13-50
- By:
- Publication type:
- Article